Mechanisms in Protein O-Glycan Biosynthesis and Clinical and Molecular Aspects of Protein O-Glycan Biosynthesis Defects: A Review
Open Access
- 1 April 2006
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 52 (4) , 574-600
- https://doi.org/10.1373/clinchem.2005.063040
Abstract
Background: Genetic diseases that affect the biosynthesis of protein O-glycans are a rapidly growing group of disorders. Because this group of disorders does not have a collective name, it is difficult to get an overview of O-glycosylation in relation to human health and disease. Many patients with an unsolved defect in N-glycosylation are found to have an abnormal O-glycosylation as well. It is becoming increasingly evident that the primary defect of these disorders is not necessarily localized in one of the glycan-specific transferases, but can likewise be found in the biosynthesis of nucleotide sugars, their transport to the endoplasmic reticulum (ER)/Golgi, and in Golgi trafficking. Already, disorders in O-glycan biosynthesis form a substantial group of genetic diseases. In view of the number of genes involved in O-glycosylation processes and the increasing scientific interest in congenital disorders of glycosylation, it is expected that the number of identified diseases in this group will grow rapidly over the coming years.Keywords
This publication has 218 references indexed in Scilit:
- Clinical and biochemical presentation of siblings with COG‐7 deficiency, a lethal multiple O‐ and N‐glycosylation disorderJournal of Inherited Metabolic Disease, 2004
- The homozygous M712T mutation of UDP‐N‐acetylglucosamine 2‐epimerase/N‐acetylmannosamine kinase results in reduced enzyme activities but not in altered overall cellular sialylation in hereditary inclusion body myopathyFEBS Letters, 2004
- Characterization of a novel human UDP‐GalNAc transferase, pp‐GalNAc‐T15FEBS Letters, 2004
- Post-translational disruption of dystroglycan–ligand interactions in congenital muscular dystrophiesNature, 2002
- Deficiency of α-Dystroglycan in Muscle–Eye–Brain DiseaseBiochemical and Biophysical Research Communications, 2002
- Macular corneal dystrophy type I and type II are caused by distinct mutations in a new sulphotransferase geneNature Genetics, 2000
- Impaired Galactosylation of Core 2 O-Glycans in Erythrocytes of β1,4-Galactosyltransferase Knockout MiceBiochemical and Biophysical Research Communications, 1999
- Achondrogenesis type IB is caused by mutations in the diastrophic dysplasia sulphate transporter geneNature Genetics, 1996
- Hereditary disorders among Iranian JewsAmerican Journal of Medical Genetics, 1995
- The phenotypic variability of diastrophic dysplasiaThe Journal of Pediatrics, 1978